Gaithersburg, MD, November 28, 2021– Safest Drug is responding to the public health crisis of medication injuries and deaths (medication harm) in the U.S. by inviting the public to…
Author: Safest Drug
PRESS RELEASE: New Board Member
Gaithersburg, MD – Safest Drug is pleased to welcome Alex Evans PharmD, MBA, as a Board member for the 2021 term which started in January. In addition to Board service, Evans will be serving on the Public Relations and Communications Committee.
PRESS RELEASE: Safest Drug Participates in Giving Tuesday, joining millions around the world in the global generosity movement on December 1, 2020
Gaithersburg, MD – Safest Drug is responding to the public health crisis of medication injuries and deaths (medication harm) in the U.S. by inviting the public to a special…
PRESS RELEASE: Demands for Statewide Legislation to Mandate Patient Counseling
Safest Drug Calls for Statewide Legislation Mandating Patient Counseling for Prescribed Drugs in Minnesota, California, Utah, New Jersey, South Carolina and North Carolina
Pharmacist’s Corner: What You Need to Know About Hydroxychloroquine
By Marina Entin, Rph, BS Hydroxychloroquine is in a class of drugs called antimalarials. It is used primarily in the prevention and treatment of malaria. It works by killing the…
A Nation’s Cry & A Moment for Greater Diversity in Clinical Trials
Since 2020 began, the U.S. Food & Drug Administration (FDA) has approved at least twenty new drugs for use by American consumers, but over 90% of those drugs were tested…
Staying Medication Safe During the COVID-19 Pandemic Response
During this time of nationwide concern and response to address the COVID-19 pandemic, Safest Drug is urging the general public to be even more cautious about how to lower their risk…
PRESS RELEASE: Safest Drug Launches “Ask, Read, Report” Campaign
CHAPEL HILL, N.C. – Safest Drug is launching its first education campaign, a medication safety initiative called “Ask, Read, Report”. The purpose of the campaign is to create safer healthcare consumers…
Popular Antidepressant Among Pharmaceutical Drugs With Labeling Updates
Cymbalta, a popular antidepressant medication is among the more than 90 entries of drugs with safety-related labeling changes released this month, so far, by the FDA. FDA-approved in 2004, Cymbalta…
FDA Releases New Black Box Warning Updates on 13 Drugs
Last month, a list of 13 medications received new black boxed warning changes, according to the FDA’s Drug Safety-Related Labeling Changes page. Since the 1970s, the FDA has regularly issued…